Abstract
Repetitive transorbital alternating current stimulation (rtACS) is a new option for the treatment of patients with low vision, and several studies report the benefit of rtACS in both pre- and postchiasmatic pathologies.1 However, it is also common clinical experience that the effect of this treatment is rather variable between patients, even with the same pathology.2 This variability probably reflects two intertwined factors, the mechanism of action of rtACS and the characteristic of patients under treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
